223 related articles for article (PubMed ID: 22549076)
1. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β.
Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M
J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076
[TBL] [Abstract][Full Text] [Related]
2. A novel reporter gene assay for interferons based on CHO-K1 cells.
Smilović V; Caserman S; Fonda I; Gaberc-Porekar V; Menart V
J Immunol Methods; 2008 Apr; 333(1-2):192-6. PubMed ID: 18295789
[TBL] [Abstract][Full Text] [Related]
3. Virus free, cell-based assay for the quantification of murine type I interferons.
Bollati-Fogolín M; Müller W
J Immunol Methods; 2005 Nov; 306(1-2):169-75. PubMed ID: 16209875
[TBL] [Abstract][Full Text] [Related]
4. Validation of a HeLa Mx2/Luc reporter cell line for the quantification of human type I interferons.
Seo YJ; Kim GH; Kwak HJ; Nam JS; Lee HJ; Suh SK; Baek KM; Sohn YW; Hong SH
Pharmacology; 2009; 84(3):135-44. PubMed ID: 19684437
[TBL] [Abstract][Full Text] [Related]
5. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
Meager A; Das RG
J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
[TBL] [Abstract][Full Text] [Related]
6. A recombinant CHSE-214 cell line expressing an Mx1 promoter-reporter system responds to both interferon type I and type II from salmonids and represents a versatile tool to study the IFN-system in teleost fish.
Jørgensen JB; Johansen A; Hegseth MN; Zou J; Robertsen B; Collet B; Secombes CJ
Fish Shellfish Immunol; 2007 Dec; 23(6):1294-303. PubMed ID: 17804253
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
[TBL] [Abstract][Full Text] [Related]
8. Post HCV Infection Due to MX Gene Stimulation Produced Post Treatment with Imported and Locally Produced Egyptian Biosimilar IFN.
Mohamed SH; Mahmoud NF; Mohamed AF; Kotb NS
Asian Pac J Cancer Prev; 2015; 16(14):5635-41. PubMed ID: 26320428
[TBL] [Abstract][Full Text] [Related]
9. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G
Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
[TBL] [Abstract][Full Text] [Related]
10. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cell viability induced by IFN-alpha generates impaired data on antiviral assay using Hep-2C cells.
de Oliveira ER; Lima BM; de Moura WC; Nogueira AC
J Immunol Methods; 2013 Dec; 400-401():97-105. PubMed ID: 24211646
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Atlantic salmon type-I interferon using an Mx1 promoter reporter gene assay.
Johansen A; Collet B; Sandaker E; Secombes CJ; Jørgensen JB
Fish Shellfish Immunol; 2004 Feb; 16(2):173-84. PubMed ID: 15123321
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
Atreya PL; Kulkarni S
Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
[TBL] [Abstract][Full Text] [Related]
14. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
16. Biological characterisation of a recombinant Atlantic salmon type I interferon synthesized in Escherichia coli.
Ooi EL; Verjan N; Hirono I; Nochi T; Kondo H; Aoki T; Kiyono H; Yuki Y
Fish Shellfish Immunol; 2008 May; 24(5):506-13. PubMed ID: 18329900
[TBL] [Abstract][Full Text] [Related]
17. Screening and characterization of molecules that modulate the biological activity of IFNs-I.
Bürgi M; Zapol'skii VA; Hinkelmann B; Köster M; Kaufmann DE; Sasse F; Hauser H; Etcheverrigaray M; Kratje R; Bollati-Fogolín M; Oggero M
J Biotechnol; 2016 Sep; 233():6-16. PubMed ID: 27346232
[TBL] [Abstract][Full Text] [Related]
18. Mouse adenovirus type 1 replication in vitro is resistant to interferon.
Kajon AE; Spindler KR
Virology; 2000 Aug; 274(1):213-9. PubMed ID: 10936102
[TBL] [Abstract][Full Text] [Related]
19. Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases.
Carlow DA; Teh SJ; Teh HS
J Immunol; 1998 Sep; 161(5):2348-55. PubMed ID: 9725230
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs.
Ghazawi I; Cutler SJ; Low P; Mellick AS; Ralph SJ
J Interferon Cytokine Res; 2005 Feb; 25(2):92-102. PubMed ID: 15695930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
